UK study of 1.4 million women links multiple pregnancy complications to elevated cardiometabolic-renal disease rates
Observational UK data show several pregnancy complications predict higher rates of cardiovascular disease, diabetes, hypertension, and chronic kidney disease. Associations hold after accounting for multiple pregnancies yet remain non-causal. Adding reproductive history to risk models could improve early prevention.
The BMJ Medicine cohort linked primary-care and hospital records for women registered between 2000 and 2022. Gestational hypertension tripled subsequent hypertension incidence and doubled chronic kidney disease; gestational diabetes raised type 2 diabetes sevenfold. Postnatal depression increased all four outcomes 35-56 percent, while miscarriage, stillbirth, and preterm birth showed smaller but consistent associations with at least one endpoint.
Prior work, including a 2018 Circulation meta-analysis and a 2021 Lancet Diabetes & Endocrinology review, established preeclampsia and gestational diabetes as independent cardiovascular and renal risk markers. This study extends those findings by capturing complications across all recorded pregnancies rather than the index pregnancy alone and by including chronic kidney disease as an explicit outcome.
Because the design is observational, pregnancy complications function as risk signals rather than proven causal triggers. Missing data on ethnicity for 20 percent of participants and absent lifestyle covariates limit adjustment for confounding. The postpartum window nevertheless offers an underused opportunity to recalibrate risk models with reproductive history.
Next steps require prospective cohorts that add pregnancy history to established scores such as QRISK3 and test whether targeted lifestyle or pharmacologic interventions begun within one year postpartum reduce five-year event rates by at least 20 percent.
VITALIS: Within 36 months, at least two major European guidelines will incorporate any adverse pregnancy outcome into cardiovascular risk stratification for women under 50, conditional on validation in an independent cohort of 500,000.
Sources (3)
- [1]Primary Source(https://bmjmedicine.bmj.com/content/3/1/e000934)
- [2]Supporting Source(https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.036748)
- [3]Supporting Source(https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00079-4/fulltext)